David Portnoy - 15 Aug 2025 Form 4 Insider Report for CRYO CELL INTERNATIONAL INC (CCEL)

Role
Chairman, Co-CEO, Director, 10%+ Owner
Signature
/s/ David Portnoy
Issuer symbol
CCEL
Transactions as of
15 Aug 2025
Net transactions value
+$85,078
Form type
4
Filing time
19 Aug 2025, 17:00:08 UTC
Previous filing
18 Aug 2025
Next filing
27 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PORTNOY DAVID Chairman, Co-CEO, Director, 10%+ Owner 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR /s/ David Portnoy 19 Aug 2025 0001315416

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCEL Common Stock Purchase $12,020 +2,671 +2.2% $4.50 125,509 15 Aug 2025 By 401K F7
transaction CCEL Common Stock Purchase $28,432 +6,418 +2.8% $4.43 237,039 15 Aug 2025 By IRA F8
transaction CCEL Common Stock Purchase $40,759 +9,327 +7.4% $4.37 134,836 18 Aug 2025 By 401K F9
transaction CCEL Common Stock Purchase $3,867 +885 +0.66% $4.37 135,721 19 Aug 2025 By 401K
holding CCEL Common Stock 804,742 15 Aug 2025 Direct
holding CCEL Common Stock 102,586 15 Aug 2025 By Spouse
holding CCEL Common Stock 152,882 15 Aug 2025 By Corporation F5
holding CCEL Common Stock 15,611 15 Aug 2025 as Custodian for daughter
holding CCEL Common Stock 59,027 15 Aug 2025 By LLC
holding CCEL Common Stock 55,219 15 Aug 2025 By Corporation F6
holding CCEL Common Stock 11,352 15 Aug 2025 As Custodian for son
holding CCEL Common Stock 11,242 15 Aug 2025 As Custodian for son
holding CCEL Common Stock 10,783 15 Aug 2025 As custodian for son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CCEL Stock Option 26,243 15 Aug 2025 Common stock 26,243 $7.53 Direct
holding CCEL Stock Option 23,636 15 Aug 2025 Common Stock 23,636 $7.28 Direct
holding CCEL Stock Option 280,000 15 Aug 2025 Common Stock 280,000 $12.27 Direct F1
holding CCEL Stock Option 50,000 15 Aug 2025 Common Stock 50,000 $4.77 Direct F2
holding CCEL Stock Option 50,000 15 Aug 2025 Common Stock 50,000 $4.30 Direct
holding CCEL Stock Option 50,000 15 Aug 2025 Common Stock 50,000 $6.47 Direct F3
holding CCEL Stock Option 50,000 15 Aug 2025 Common Stock 50,000 $8.08 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
F2 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
F3 Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
F4 Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
F5 Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
F6 Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
F7 The price reported is a weighted average price. These shares were purchased in multiple transactions at $4.50.
F8 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.34 to $4.50, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F9 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.23 to $4.50, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.